Published Date: 20-11-2018
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report LAMEA Intermittent Catheters Market, published by KBV research, the LAMEA Intermittent Catheters Market would witness market growth of 9.7% CAGR during the forecast period (2018 – 2024).
The Brazil market would dominate the LAMEA Intermittent Catheter in Hospitals Market by Country by 2024, growing at a CAGR of 9.9 % during the forecast period. The Argentina market is expected to witness a CAGR of 9.8% during (2018 - 2024). Additionally, The UAE market is expected to witness a CAGR of 7.1% during (2018 - 2024).
The Non-Coated Intermittent Catheter market dominated the LAMEA Intermittent Catheter Market by Product in 2017. The Coated Intermittent Catheter market is expected to witness a CAGR of 10.7% during (2018 - 2024). The Non-Coated Intermittent Catheter market is expected to witness a CAGR of 8.9% during (2018 - 2024).
The Urinary Incontinence market dominated the UAE Intermittent Catheter Market by Indication in 2017, and would achieve a market value of $18.7 million by 2024. The Other Indications market is expected to witness a CAGR of 8.6% during (2018 - 2024).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Becton Dickinson Company, B. Braun Melsungen AG, Coloplast Ltd., C. R. Bard, Inc., Hollister Incorporated, Medical Technologies of Georgia Inc., Teleflex Incorporated, Pennine Healthcare, Adapta Medical, ConvaTec Inc.
By End User
Unique Offerings from KBV Research